Determination of ospemifene in human plasma by LC-MS/MS and its application to a human pharmacokinetic study

Biomed Chromatogr. 2019 Apr;33(4):e4451. doi: 10.1002/bmc.4451. Epub 2019 Jan 7.

Abstract

A highly sensitive, specific and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) analytical method has been developed and validated for the determination of ospemifene in human plasma using ospemifene-d4 as an internal standard. Solid-phase extraction technique with Phenomenex Strata X-33 μm polymeric sorbent cartridges (30 mg/1 mL) was used to extract the analytes from the plasma. The chromatographic separation was achieved on Agilent Eclipse XDB-Phenyl, 4.6 × 75 mm, 3.5 μm column using the mobile phase composition of methanol and 20 mm ammonium formate buffer (90:10, v/v) at a flow rate of 0.9 mL/min. A detailed method validation was performed as per the US Food and Drug Administration guidelines and the calibration curve obtained was linear (r2 = 99) over the concentration range 5.02-3025 ng/mL. The API-4500 MS/MS was operated under multiple reaction monitoring mode during the analysis. The proposed method was successfully applied to a pharmacokinetic study in healthy human volunteers after oral administration of an ospemifene 60 mg tablet under fed conditions.

Keywords: LC-MS/MS; human plasma; method validation; ospemifene; solid-phase extraction.

MeSH terms

  • Adult
  • Chromatography, High Pressure Liquid / methods*
  • Drug Stability
  • Female
  • Humans
  • Limit of Detection
  • Linear Models
  • Male
  • Reproducibility of Results
  • Tamoxifen / analogs & derivatives*
  • Tamoxifen / blood
  • Tamoxifen / chemistry
  • Tamoxifen / pharmacokinetics
  • Tandem Mass Spectrometry / methods*
  • Young Adult

Substances

  • Tamoxifen
  • Ospemifene